Max Robotics — Global Service Robot Directory + US Certification

About

Young Suk Kwon is a urologic surgeon and researcher whose work spans surgical innovation, oncologic risk stratification, and medical education. His most impactful contributions address the intersection of clinical safety and training adaptability. In the wake of the COVID-19 pandemic, Kwon authored a seminal paper on adapting urology residency training during global disruption, which has garnered over 70 citations and provided a critical framework for maintaining surgical education under crisis conditions. His research on neutrophil and lymphocyte counts as clinical markers for stratifying low-risk prostate cancer (50 citations) offers a non-invasive, cost-effective tool to guide treatment decisions, potentially reducing overtreatment. Kwon also advanced the safety profile of robot-assisted radical prostatectomy by demonstrating that a pneumoperitoneum of 20 mm Hg—higher than the conventional 15 mm Hg—can be safely used in over 750 patients, improving intraoperative visualization without increasing complications. Additionally, his case report on renal leiomyosarcoma contributes to the sparse literature on this rare malignancy. Through these works, Kwon has demonstrated a commitment to evidence-based surgical practice, patient-centered risk assessment, and the resilience of urologic training.